Navigation Links
TeamStaff Receives A Letter of Reprimand From Nasdaq; No Further Action Contemplated
Date:9/28/2007

SOMERSET, N.J., Sept. 28 /PRNewswire-FirstCall/ -- TeamStaff, Inc. (Nasdaq: TSTF) a national provider of healthcare and administrative staffing services, today announced that it had received a letter of reprimand from Nasdaq concerning the membership of the Company's Nominating and Corporate Governance Committee.

The Nasdaq Marketplace Rule 4350(c)(4)(A) requires that all nominees for director be either recommended or selected by a majority of independent directors or by a Committee comprised solely of independent directors. The nominees for director were recommended by the Company's Nominating and Corporate Governance Committee. However, since one of the members of the Committee was previously employed by the Company within three years, the Committee was not composed entirely of "independent" directors as defined in Nasdaq Marketplace Rule 4200(a)(15).

Upon receiving notice of the violation, the Company took immediate corrective action. The Company noted the violation was inadvertent and the Company's Board of Directors consists of a majority of independent directors.

About TeamStaff, Inc.

Headquartered in Somerset, New Jersey, TeamStaff serves clients and their employees throughout the United States as a full-service provider of medical and administrative staffing. TeamStaff is a leading provider of nursing and allied healthcare professionals and operates through three medical staffing units. TeamStaff's RS Staffing subsidiary specializes in providing medical and office administration/technical professionals through nationwide schedule contracts with both the General Services Administration and Veterans Affairs. The TeamStaff Rx subsidiary operates throughout the US and specializes in the sup
'/>"/>

SOURCE TeamStaff, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...n (a) levels boost cardiovascular disease risk fo...y News) -- If you,re worried about reducing your r...at you should quit smoking, eat a healthful diet, ...eck, and make sure your cholesterol levels aren,t ...ein (a) levels are? , Well, if you don,t have ...
(Date:10/10/2008)...mpany committed to helping people address health n.../ -- In these troubling,economic times, people may... may feel that they don,t have the money to visit ...a survey by the National Association of,Insurance ... -- Twenty-two percent of Americans say that they ...
(Date:10/10/2008)...Oct. 10 /PRNewswire/ -- Do you think that the blin...d town? Attend the October,17 open house at the Vi...ion Impaired, and see how instructors there empowe...ve, fulfilling lives through non-visual,techniques...1 Azalea Avenue, is holding an open house to,celeb...
(Date:10/10/2008)...omy serving as tipping point for behavior change, ...-- More than half of,Americans (51 percent) believ...are system, but major changes are needed, accordin...urvey was released today by the,Employee Benefit R...tes,Inc., and was underwritten by the Principal Fi...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3
...diabetes, and arthritis are among a variety of aut... of white blood cell, called the immune regulatory...s malfunction is when a mutation in the FOXP3 gene...In a new study published online this week in the P...
...cted on mice shows that more copper in everyday di...ducted by scientists at the University of Louisvil...esearch Center. Their studies show that giving co...ress on their over-worked hearts by preventing hea...
...cted by American Academy of Neurology finds that e...providing short-term pain relief for lower back pa...long-term pain relief. To develop the guideline, ...c studies on the topic. According to the guidelin...
...time. An extra hour to enjoy life outside. An extr.../ . What should we do when the clock jukes and ji...aves that regulate our sleep? It’s bad enough for... concept. What about kids, who will want to squeez...
Other Medicine News:Health News:Researchers Discover New Molecular Path to Fight Autoimmune Diseases 2Health News:Use Daylight-saving Change to Practice Healthy Sleep Habits 2
(Date:10/8/2008)... LYON, France, Oct. 8 /- Vical In...panded clinical data and new nonclinical data,demo... may be broadly,applicable in DNA- and protein-bas...ancer vaccines. Alain P. Rolland, Pharm.D., Ph.D.,...ent, will present the data today,Wednesday, Octob...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
(Date:10/7/2008)... Study Showed Larazotide Acetate Prevented Immun...n Patients with Celiac Disease, Additional Data In...isease, ORLANDO, Fla., Oct. 7 /- Alb...two clinical studies this week at the American,Col...fic Meeting. Data from,study CLIN 1001-004, the fi...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Sci...ire-FirstCall/ -- Ironwood,Pharmaceuticals, Inc. (...Inc. (NYSE: FRX ) today announced the presentatio...lotide,s safety and efficacy in 420 patients with,.... Analysis of the data,indicates that once- daily ...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Your belly fat could be making you hungrier 17023 1Your belly fat could be making you hungrier 17023 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 1GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 3The Miracle of Funding by State and Local Pension Plans 17016 1The Miracle of Funding by State and Local Pension Plans 17016 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 1AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 3
...o., March 06, 2007 /PRNewswire-FirstCall/ --,Repli...ts Phase II,clinical trial using faropenem medoxom...itis media (AOM), a common infection of the,middle...hat it met,its primary objective to show that faro...the middle ear and to permit the dose,selection fo...
...., March 06, 2007 /PRNewswire-FirstCall/ --,Advanc...completed,Phase III multi- center clinical studies... therapeutic will be presented during,the National...ings,taking place April 10th through 14th in Orlan...cheduled to be presented on,Wednesday, April 11, 2...
Other Medicine Technology:Replidyne Phase II Pediatric Trial Meets Primary Objective 2Replidyne Phase II Pediatric Trial Meets Primary Objective 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4
Portable shields for your safety and convenience.
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures.
0.5 mm Pb protection with height-adjustment for patient and practitioner. Measures 18"L x 24"W adjusts 36" to 56" in height at lowest height (36") bottom hem remains 12" from floor. 5 leg base for ma
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre
Medicine Products: